Fundz

Adial Pharmaceuticals Appoints Celia Economides as Chief Financial Officer

PUBLIC · ADILOct 26, 2026
Internal move“Economides, currently the Executive Vice President of Finance, will succeed Vinay Shah in this role.”

Position

Chief Executive Officer

Company

Adial Pharmaceuticals

Matt Davidson
Glen AllenBiotechnologyHealthcareHealth CareTherapeuticsPharmaceutical

Description

Adial Pharmaceuticals has announced the expected appointment of Celia Economides as Chief Financial Officer following the approval of certain proposals at the 2026 Annual Meeting of Stockholders. Economides, currently the Executive Vice President of Finance, will succeed Vinay Shah in this role.

Who to call at Adial Pharmaceuticals, and when

A new leader at Adial Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Adial Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Adial Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Adial Pharmaceuticals. With Fundz connected, it knows.

See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Adial Pharmaceuticals

Location

Glen Allen, Virginia, United States

About

Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions and related disorders. The Company's lead investigational new drug product, AD04, is a genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder (AUD) in heavy drinking patients and was recently investigated in the Company's ONWARDTM pivotal Phase 3 clinical trial for the potential treatment of AUD in subjects with certain target genotypes (estimated to be approximately one-third of the AUD population) identified using the Company's companion diagnostic genetic test. ONWARD showed promising results in reducing drinking in heavy drinking patients, and no overt safety or tolerability concerns. AD04 is also believed to have the potential to treat other addictive disorders such as Opioid Use Disorder, gambling, and obesity. Additional information is available at www.adial.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Adial Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Cary
Senior decision-maker at this company
••••••••@••••••••

See Cary's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Adial Pharmaceuticals's next move

Learn about Strategic plan

Adial Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.